
Puma Biotechnology Inc: shareholders and insiders
Price
$7.05
November 20, 2026Market cap $359M
What Ploutos Investor adds for Puma Biotechnology
Part of Ploutos Investor, €9.99 a month
- The full history: 9 fiscal years, from 2017
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors from Nov 21, 2025 to Nov 13, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$2.1M
10 people
From Nov 21, 2025 to Nov 21, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan94%
- The rest6%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 21, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $2.1M by 10 people
- 2025: no buys, no sales
- 2026: no buys, sold $2.1M by 10 people
- Nov 11, 2026Michael Patrick MillerDirectorKind
- Sep 14, 2026Troy Edward WilsonDirectorKind10b5-1
- Sep 14, 2026Alessandra CesanoDirectorKind10b5-1
- Sep 14, 2026Alessandra CesanoDirectorKind10b5-1
- Jul 6, 2026Alan H AuerbachPresident and CEOKind10b5-1
- Jul 6, 2026Douglas M HuntThe Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.Kind10b5-1
- Jul 6, 2026Maximo F NouguesChief Financial OfficerKind10b5-1
- Jun 12, 2026Troy Edward WilsonDirectorKind10b5-1
- Jun 12, 2026Brian M StuglikDirectorKind10b5-1
- Jun 12, 2026Adrian SenderowiczDirectorKind10b5-1
- Jun 12, 2026Jay M MoyesDirectorKind10b5-1
- Jun 12, 2026Allison DorvalDirectorKind10b5-1
- Jun 11, 2026Troy Edward WilsonDirectorKind10b5-1
- Jun 11, 2026Brian M StuglikDirectorKind10b5-1
- Jun 11, 2026Adrian SenderowiczDirectorKind10b5-1
- Jun 11, 2026Michael Patrick MillerDirectorKind
- Jun 11, 2026Jay M MoyesDirectorKind10b5-1
- Jun 11, 2026Allison DorvalDirectorKind10b5-1
- Jun 11, 2026Alessandra CesanoDirectorKind
- Jan 7, 2026Maximo F NouguesChief Financial OfficerKind10b5-1
- Jan 7, 2026Douglas M HuntKind10b5-1
- Jan 7, 2026Alan H AuerbachPresident and CEOKind10b5-1
- Jan 6, 2026Maximo F NouguesChief Financial OfficerKind10b5-1
- Jan 6, 2026Douglas M HuntKind10b5-1
- Jan 6, 2026Alan H AuerbachPresident and CEOKind10b5-1
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | Michael Patrick MillerDirector | 15.0K | $8.10 | $121.5K | Form 4 | |
| Sep 14, 2026 | Troy Edward WilsonDirector | 10b5-1 | 5,000 | $9.10 | $45.5K | Form 4 |
| Sep 14, 2026 | Alessandra CesanoDirector | 10b5-1 | 50.0K | $2.93 | $146.5K | Form 4 |
| Sep 14, 2026 | Alessandra CesanoDirector | 10b5-1 | 62.2K | $9.12 | $567.0K | Form 4 |
| Jul 6, 2026 | Alan H AuerbachPresident and CEO | 10b5-1 | 44.1K | $8.26 | $364.1K | Form 4 |
| Jul 6, 2026 | Douglas M HuntThe Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer. | 10b5-1 | 8,460 | $8.26 | $69.9K | Form 4 |
| Jul 6, 2026 | Maximo F NouguesChief Financial Officer | 10b5-1 | 9,386 | $8.26 | $77.6K | Form 4 |
| Jun 12, 2026 | Troy Edward WilsonDirector | 10b5-1 | 10.8K | $7.20 | $77.7K | Form 4 |
| Jun 12, 2026 | Brian M StuglikDirector | 10b5-1 | 8,100 | $7.20 | $58.3K | Form 4 |
| Jun 12, 2026 | Adrian SenderowiczDirector | 10b5-1 | 27.0K | $7.20 | $194.3K | Form 4 |
| Jun 12, 2026 | Jay M MoyesDirector | 10b5-1 | 22.0K | $7.22 | $158.8K | Form 4 |
| Jun 12, 2026 | Allison DorvalDirector | 10b5-1 | 11.6K | $7.20 | $83.6K | Form 4 |
| Jun 11, 2026 | Troy Edward WilsonDirector | 10b5-1 | 27.0K | – | – | Form 4 |
| Jun 11, 2026 | Brian M StuglikDirector | 10b5-1 | 27.0K | – | – | Form 4 |
| Jun 11, 2026 | Adrian SenderowiczDirector | 10b5-1 | 27.0K | – | – | Form 4 |
| Jun 11, 2026 | Michael Patrick MillerDirector | 27.0K | – | – | Form 4 | |
| Jun 11, 2026 | Jay M MoyesDirector | 10b5-1 | 27.0K | – | – | Form 4 |
| Jun 11, 2026 | Allison DorvalDirector | 10b5-1 | 27.0K | – | – | Form 4 |
| Jun 11, 2026 | Alessandra CesanoDirector | 27.0K | – | – | Form 4 | |
| Jan 7, 2026 | Maximo F NouguesChief Financial Officer | 10b5-1 | 6,405 | $5.88 | $37.7K | Form 4 |
| Jan 7, 2026 | Douglas M Hunt | 10b5-1 | 5,014 | $5.88 | $29.5K | Form 4 |
| Jan 7, 2026 | Alan H AuerbachPresident and CEO | 10b5-1 | 18.0K | $5.88 | $105.9K | Form 4 |
| Jan 6, 2026 | Maximo F NouguesChief Financial Officer | 10b5-1 | 4,540 | $5.84 | $26.5K | Form 4 |
| Jan 6, 2026 | Douglas M Hunt | 10b5-1 | 3,973 | $5.84 | $23.2K | Form 4 |
| Jan 6, 2026 | Alan H AuerbachPresident and CEO | 10b5-1 | 16.9K | $5.84 | $98.9K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before Jun 15, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by PBYI's officers and directors from 2012 up to November 20, 2025, 14 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
and 9 more, back to 2012
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Alan H. AuerbachShare of class16.0%
- Acorn Bioventureswith 4 more personsShare of class8.00%
- BlackRock, Inc.Share of class5.60%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Alan H. Auerbach | 16.0% | 8.65M | Oct 6, 2026 | 13D/A | |
| Acorn Bioventureswith 4 more persons | 8.00% | 3.94M | Feb 14, 20252 filings since Nov 14, 2024 | 13G/A | |
| BlackRock, Inc. | 5.60% | 2.78M | Apr 17, 2025 | 13G/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Alan H. Auerbach16.0%From the filing of Oct 6, 2026
The information set forth or incorporated in Item 3 above is incorporated herein by reference. From time to time, Mr. Auerbach may acquire beneficial ownership of additional shares of Common Stock or other securities of the Issuer by purchase, as compensation from the Issuer, or otherwise, including, but not limited to, awards of restricted Common Shares, options to purchase Common Shares, and restricted stock units for Common Shares, or dispose of some or all of the shares of Common Stock beneficially owned by Mr. Auerbach in the open market or in privately negotiated transactions (which may be with the Issuer or with third parties) on such terms and at such times as Mr. Auerbach may deem…
From the filing of Oct 6, 2026
Fell to 5% or less (4)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Renaissance TechnologiesIn the quarter+2.6%
- Millennium Mgmt (Englander)In the quarter
- D.E. ShawIn the quarter-19%
- AQR CapitalIn the quarter-3.5%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Renaissance Technologies | 1.88M | +2.6% | $19M | 0.03% |
| Millennium Mgmt (Englander) | – | – | 0.00% | |
| D.E. Shaw | 256.1K | -19% | $2.5M | 0.00% |
| AQR Capital | 700.1K | -3.5% | $7.0M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 8.92% of its shares outstanding were held short, +6.5% since the report before.
- Shares held short
- 4.54M
- 8.92%
- Since the report before4.26M on Sep 30, 2026
- +6.5%
- 12.9
- 352.6K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 96%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 1.72M
- Nov 15, 2023: Shares held short 1.88M
- Nov 30, 2023: Shares held short 2.04M
- Dec 15, 2023: Shares held short 2.76M
- Dec 29, 2023: Shares held short 2.90M
- Jan 12, 2024: Shares held short 3.02M
- Jan 31, 2024: Shares held short 3.21M
- Feb 15, 2024: Shares held short 3.59M
- Feb 29, 2024: Shares held short 4.09M
- Mar 15, 2024: Shares held short 3.33M
- Mar 28, 2024: Shares held short 3.29M
- Apr 15, 2024: Shares held short 3.33M
- Apr 30, 2024: Shares held short 3.11M
- May 15, 2024: Shares held short 3.04M
- May 31, 2024: Shares held short 2.51M
- Jun 14, 2024: Shares held short 2.70M
- Jun 28, 2024: Shares held short 2.93M
- Jul 15, 2024: Shares held short 3.80M
- Jul 31, 2024: Shares held short 3.82M
- Aug 15, 2024: Shares held short 4.00M
- Aug 30, 2024: Shares held short 3.48M
- Sep 13, 2024: Shares held short 3.62M
- Sep 30, 2024: Shares held short 3.41M
- Oct 15, 2024: Shares held short 3.62M
- Oct 31, 2024: Shares held short 3.19M
- Nov 15, 2024: Shares held short 2.98M
- Nov 29, 2024: Shares held short 2.81M
- Dec 13, 2024: Shares held short 2.91M
- Dec 31, 2024: Shares held short 3.01M
- Jan 15, 2025: Shares held short 3.07M
- Jan 31, 2025: Shares held short 2.98M
- Feb 14, 2025: Shares held short 3.07M
- Feb 28, 2025: Shares held short 3.16M
- Mar 14, 2025: Shares held short 2.79M
- Mar 31, 2025: Shares held short 2.88M
- Apr 15, 2025: Shares held short 2.87M
- Apr 30, 2025: Shares held short 2.93M
- May 15, 2025: Shares held short 2.87M
- May 30, 2025: Shares held short 2.78M
- Jun 13, 2025: Shares held short 2.68M
- Jun 30, 2025: Shares held short 2.63M
- Jul 15, 2025: Shares held short 2.61M
- Jul 31, 2025: Shares held short 2.78M
- Aug 15, 2025: Shares held short 2.65M
- Aug 29, 2025: Shares held short 2.77M
- Sep 15, 2025: Shares held short 3.40M
- Sep 30, 2025: Shares held short 3.52M
- Oct 15, 2025: Shares held short 3.36M
- Oct 31, 2025: Shares held short 3.34M
- Nov 14, 2025: Shares held short 3.33M
- Nov 28, 2025: Shares held short 3.41M
- Dec 15, 2025: Shares held short 3.43M
- Dec 31, 2025: Shares held short 3.44M
- Jan 15, 2026: Shares held short 3.59M
- Jan 30, 2026: Shares held short 3.48M
- Feb 13, 2026: Shares held short 3.66M
- Feb 27, 2026: Shares held short 3.76M
- Mar 13, 2026: Shares held short 4.11M
- Mar 31, 2026: Shares held short 3.94M
- Apr 15, 2026: Shares held short 4.16M
- Apr 30, 2026: Shares held short 4.11M
- May 15, 2026: Shares held short 4.19M
- May 29, 2026: Shares held short 3.80M
- Jun 15, 2026: Shares held short 3.70M
- Jun 30, 2026: Shares held short 3.63M
- Jul 15, 2026: Shares held short 3.91M
- Jul 31, 2026: Shares held short 4.13M
- Aug 14, 2026: Shares held short 4.17M
- Aug 31, 2026: Shares held short 4.27M
- Sep 15, 2026: Shares held short 4.32M
- Sep 30, 2026: Shares held short 4.26M
- Oct 15, 2026: Shares held short 4.54M
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading56.9% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 56.9% of the shares in the reported trades were short sales, against 60.8% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 56.9%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 60.8%
- Change
- -3.9 pts
- Short sales a dayon average, of 225.9K shares
- 128.5K
- More than atof 3,666 US-listed companies, same days
- 74%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 72.2%
- Oct 15, 2026: Short sales 71.9%
- Oct 16, 2026: Short sales 62.3%
- Oct 19, 2026: Short sales 71.4%
- Oct 20, 2026: Short sales 65.7%
- Oct 21, 2026: Short sales 75.5%
- Oct 22, 2026: Short sales 70.7%
- Oct 23, 2026: Short sales 66.9%
- Oct 26, 2026: Short sales 70.6%
- Oct 27, 2026: Short sales 63%
- Oct 28, 2026: Short sales 31.7%
- Oct 29, 2026: Short sales 43.8%
- Oct 30, 2026: Short sales 55.1%
- Nov 2, 2026: Short sales 34.6%
- Nov 3, 2026: Short sales 52.4%
- Nov 4, 2026: Short sales 52%
- Nov 5, 2026: Short sales 54.6%
- Nov 6, 2026: Short sales 63.4%
- Nov 9, 2026: Short sales 65%
- Nov 10, 2026: Short sales 71%
- Nov 11, 2026: Short sales 46%
- Nov 12, 2026: Short sales 59.2%
- Nov 13, 2026: Short sales 56.9%
- Nov 16, 2026: Short sales 52.8%
- Nov 17, 2026: Short sales 49.7%
- Nov 18, 2026: Short sales 56%
- Nov 19, 2026: Short sales 52.4%
- Nov 20, 2026: Short sales 41.1%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Alan H AuerbachPresident and CEODirectly7.26M
- Maximo F NouguesChief Financial OfficerDirectly230.6K
- Douglas M HuntSee RemarksDirectly196.8K
- Brian M StuglikDirectorDirectly113.9K
- Jeffrey Jerome LudwigChief Commercial OfficerDirectly109.0K
- Alvin F WongChief Scientific OfficerDirectly98.2K
- Allison DorvalDirectorDirectly90.8K
- Michael Patrick MillerDirectorDirectly66.0K
- Jay M MoyesDirectorDirectly58.3K
- Alessandra CesanoDirectorDirectly56.7K
- Troy Edward WilsonDirectorDirectly54.8K
- Adrian SenderowiczDirectorDirectly27.0K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Alan H AuerbachPresident and CEO | 7.26M | – | Jul 6, 2026 | Form 4 |
| Maximo F NouguesChief Financial Officer | 230.6K | – | Jul 6, 2026 | Form 4 |
| Douglas M HuntSee Remarks | 196.8K | – | Jul 6, 2026 | Form 4 |
| Brian M StuglikDirector | 113.9K | – | Jun 12, 2026 | Form 4 |
| Jeffrey Jerome LudwigChief Commercial Officer | 109.0K | – | Jan 2, 2025 | Form 4 |
| Alvin F WongChief Scientific Officer | 98.2K | – | Jan 3, 2024 | Form 4 |
| Allison DorvalDirector | 90.8K | – | Jun 12, 2026 | Form 4 |
| Michael Patrick MillerDirector | 66.0K | – | Nov 11, 2026 | Form 4 |
| Jay M MoyesDirector | 58.3K | – | Jun 12, 2026 | Form 4 |
| Alessandra CesanoDirector | 56.7K | – | Sep 14, 2026 | Form 4 |
| Troy Edward WilsonDirector | 54.8K | – | Sep 14, 2026 | Form 4 |
| Adrian SenderowiczDirector | 27.0K | – | Jun 12, 2026 | Form 4 |
A lower bound: it counts only the 12 officers and directors with a market trade since Nov 22, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.08%
- AVUVAvantis U.S. Small Cap Value ETFWeight in the fund0.07%
- FESMFidelity Enhanced Small Cap Core ETFWeight in the fund0.02%
- IWNiShares Russell 2000 Value ETFWeight in the fund0.02%
- VTWOVanguard Russell 2000 Index FundWeight in the fund0.01%
- IWMiShares Russell 2000 ETFWeight in the fund0.01%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.01%
- DFSVDimensional US Small Cap Value ETFWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- IWOiShares Russell 2000 Growth ETFWeight in the fund0.00%
15 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 132
- Q4 2025: Managers 151
- Q1 2026: Managers 158
- Q2 2026: Managers 161
Institutional investors by quarter
The fund managers holding PBYI, quarter by quarter, from Q1 2013 to Q2 2025, 50 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 161 managers held 38.67M shares, worth $314M. During the quarter 22 opened a position, 19 closed one, 57 added and 51 trimmed.
The largest holders, Q2 2026
- Acorn Capital AdvisorsIn the quarter
- BlackRockIn the quarter+5.7%
- American Century CompaniesIn the quarter+21%
- Acadian Asset ManagementIn the quarter+0.6%
- Renaissance TechnologiesIn the quarter-5.5%
- Vanguard Capital ManagementIn the quarter+1.0%
- Vanguard Portfolio ManagementIn the quarter+5.2%
- LSV Asset ManagementIn the quarter+37%
- Dimensional Fund AdvisorsIn the quarter+5.7%
- Geode Capital ManagementIn the quarter+32%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Acorn Capital Advisors | 4.13M | $34M | |
| BlackRock | 3.80M | +5.7% | $31M |
| American Century Companies | 2.32M | +21% | $19M |
| Acadian Asset Management | 2.05M | +0.6% | $17M |
| Renaissance Technologies | 1.84M | -5.5% | $15M |
| Vanguard Capital Management | 1.84M | +1.0% | $15M |
| Vanguard Portfolio Management | 1.83M | +5.2% | $15M |
| LSV Asset Management | 1.62M | +37% | $13M |
| Dimensional Fund Advisors | 1.52M | +5.7% | $12M |
| Geode Capital Management | 1.34M | +32% | $11M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Puma Biotechnology's filings show?
Who buys and sells is one part of Puma Biotechnology's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have PBYI's insiders bought or sold?
From Jun 15, 2026 to Nov 13, 2026 Puma Biotechnology's insiders bought 0 and sold $1.8M of shares on the market. 93% of the sales were under set 10b5-1 plans.
Which well-known managers hold PBYI?
4 of the managers we track held the shares on Sep 30, 2026. The largest position was Renaissance Technologies's, worth $19M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.